Derin Keskin

Derin Keskin

Harvard University

H-index: 42

North America-United States

About Derin Keskin

Derin Keskin, With an exceptional h-index of 42 and a recent h-index of 30 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Immuno-oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Comparative molecular profiling of sporadic and Lynch syndrome MSI tumors: Unraveling insights for vaccine design

Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination

Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma

Abstract A083: Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer

Dictionary of immune responses to cytokines at single-cell resolution

Abstract SY41-01: Selection of targeted neoantigens for personalized cancer vaccines

Protocol for Classification Single-Cell PBMC Types from Pathological Samples Using Supervised Machine Learning

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies

Derin Keskin Information

University

Position

Broad Institute

Citations(all)

12471

Citations(since 2020)

7702

Cited By

7424

hIndex(all)

42

hIndex(since 2020)

30

i10Index(all)

82

i10Index(since 2020)

65

Email

University Profile Page

Harvard University

Google Scholar

View Google Scholar Profile

Derin Keskin Skills & Research Interests

Immuno-oncology

Top articles of Derin Keskin

Title

Journal

Author(s)

Publication Date

Comparative molecular profiling of sporadic and Lynch syndrome MSI tumors: Unraveling insights for vaccine design

Cancer Research

Hagay Ladany

Mark Grossman

Julian Hess

Nicole Lu

Derin Keskin

...

2024/3/22

Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination

Nature Nanotechnology

Yang C Zeng

Olivia J Young

Christopher M Wintersinger

Frances M Anastassacos

James I MacDonald

...

2024/3/15

Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma

Blood

Jooeun Bae

Shuichi Kitayama

Zach Herbert

Laurence Daheron

Keiji Kurata

...

2023/10/29

Abstract A083: Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer

Cancer Research

MacLean C Sellars

Rebecca Porter

Ruolin Liu

Alexis A Howard

Kan Xiong

...

2024/3/4

Dictionary of immune responses to cytokines at single-cell resolution

Nature

Ang Cui

Teddy Huang

Shuqiang Li

Aileen Ma

Jorge L Pérez

...

2024/1/11

Abstract SY41-01: Selection of targeted neoantigens for personalized cancer vaccines

Cancer Research

Derin Keskin

2024/4/5

Protocol for Classification Single-Cell PBMC Types from Pathological Samples Using Supervised Machine Learning

Minjie Lyu

Lin Xin

Huan Jin

Lou T Chitkushev

Guanglan Zhang

...

2023/6/1

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies

Frontiers in immunology

Shanye Yin

Susan Klaeger

Vipheaviny A Chea

Isabel P Carulli

Suzanna Rachimi

...

2023/10/20

OP01-5 Combination immunotherapy targeting XBP1, CD138 and CS1 with cancer vaccine, checkpoint inhibitors, immune modulator, and epigenetic regulator to treat patients with …

ESMO Open

Jooeun Bae

Kristen Cowens

Alec Kimmelman

Sean Rowell

Suzan Lazo

...

2023/12/1

Abstract PR015: Tumor-specific immunity generated by a personalized neoantigen vaccination incorporating locally delivered ipilimumab in renal cell carcinoma

Cancer Research

David A Braun

Derin B Keskin

Sachet A Shukla

Bradley A McGregor

Nicholas R Schindler

...

2023/8/15

Dictionary of immune responses to 86 cytokines in vivoat single-cell resolution

The Journal of Immunology

Ang Cui

Teddy Huang

Shuqiang Li

Aileen Ma

Jorge Perez

...

2023/5/1

Abstract LB_C20: A tumor-associated chemokine attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven …

Molecular Cancer Therapeutics

Xiaodan Qin

Andrew Lam

Xu Zhang

Satyaki Sengupta

J Bryan Iorgulescu

...

2023/12/1

MA 02215, USA guanglan@ bu. edu Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA 3 School of Economics, University of Nottingham Ningbo China …

Computer Science and Education in Computer Science: 19th EAI International Conference, CSECS 2023, Boston, MA, USA, June 28–29, 2023, Proceedings

Zitian Zhen¹

Yuhe Wang

Derin B Keskin

Vladimir Brusic¹

2023/10/10

Compositions and methods for treating merkel cell carcinoma (mcc) using hla class i specific epitopes

2023/8/10

Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies

Shizuko Sei

Aysel Ahadova

Derin B Keskin

Lena Bohaumilitzky

Johannes Gebert

...

2023/3/22

The BRD4–NUT fusion alone drives malignant transformation of NUT Carcinoma

Cancer Research

R Taylor Durall

Julianna Huang

Luke Wojenski

Yeying Huang

Prafulla C Gokhale

...

2023/12/1

ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer

Nature Cancer

Ines Mota

Enrico Patrucco

Cristina Mastini

Navin R Mahadevan

Tran C Thai

...

2023/7

Erratum: Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy (Cell Reports (2021) 37 (6),(S2211124721014716),(10.1016/j. celrep …

Cell Reports

Pavan Bachireddy

Elham Azizi

Cassandra Burdziak

Vinhkhang N Nguyen

Christina S Ennis

...

2023/8/29

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma

The Journal of Clinical Investigation

Thomas C Frost

Ashley K Gartin

Mofei Liu

Jingwei Cheng

Harita Dharaneeswaran

...

2023/3/1

Methods for modulating mhc-i expression and immunotherapy uses thereof

2023/6/29

See List of Professors in Derin Keskin University(Harvard University)